Prof. Andrea De Luca, M.D. graduated in Medicine in 1989 and specialized in Infectious Diseases in 1993 at the Catholic University in Rome, Italy. Appointed as Associate Professor of Infectious Diseases at the University of Siena, Italy since June 2015. In 2013 he has received the National qualification as Full Professor of Infectious Diseases. Since 2011 he is the Director of the University Infectious Diseases Clinic at the Siena University Hospital, Siena, Italy.
Andrea De Luca is member of the Scientific Committee of the Italian Cohort I.Co.N.A of HIV-infected patients, and of the Antiviral Resistance Cohort Study and Clinical advisor for the CASCADE cohort of HIV seroconverters. He has been Chair or member of the organizing committee or the program committee of several European workshops and conferences on HIV.
Professor De Luca has published more than 260 scientific papers listed in PubMed which have been cited >6,900 times, with an H index of 46 (Web of Knowledge, June 2015). He has made over 400 conference presentations and is author of several chapters on Textbooks of Infectious Diseases.
He has been Principal Investigator in several clinical studies and trials. The research activity of Professor De Luca has focused mainly on clinical studies on the treatment of HIV infection and hepatitis virus co-infections, HIV drug resistance, pharmacokinetics and pharmacogenomics of antiretrovirals, HIV-associated central nervous system disorders.
Professor De Luca has contributed with governmental and non-governmental organizations to the development of pilot programs for the introduction of antiretroviral treatment in resource-limited countries and is member of the core group for the HIV resistance network at WHO, Geneva.